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We have used antibodies pecific for troponin I proteins to examine human cardiac development and have detected a transiently expressed 
developmental isoform. This isoform is distinct from adult cardiac troponin I (Tnlc) but is indistinguishable, onthe basis ofelectrophoretic mobility 
and antibody reactivity, from the isoform found in slow skeletal muscle (ThiS). Furthermore, we show that mRNA for Tnls is present in fetal, 
but not adult, heart. Analysis of a developmental series of fetal samples indicates that there is a transition in expression from Tnls to TnI¢ which 
occurs between 20 weeks fetal and 9 months postnatal development. 
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1. INTRODUCTION 
The troponin complex forms a calcium-sensitive 
switch on the thin filament of striated muscle which is 
involved in regulating muscle contraction. It is com- 
prised of three proteins: troponin I (TnI), troponin T 
(TnT) and troponin C (TnC). Multiple isoforms of each 
of these proteins exist and are expressed in a tissue- 
specific and developmentally regulated manner. For 
-troponin I, three principal isoforms have been described 
on the basis of protein sequencing [1,2], antibody 
studies [3-7] and, more recently, by molecular cloning 
[8-13]. These isoforms are associated' with fast skeletal 
muscle, slow skeletal muscle or cardiac muscle, and are 
referred to here as fast Tnl (Tnlf), slow Tnl (Tnls) and 
cardiac TnI (Tnlc), respectively. 
The cardiac isoform differs from those found in skele- 
tal muscle by the presence of an extended N-terminal 
sequence. This sequence contains two adjacent serine 
residues which are phosphorylated in response to fl- 
adrenergic stimulation i  the heart [14-16] as part of the 
phosphorylation-mediated control of cardiac cont-ac- 
tion by adrenergic agonists. This is an important fe,-ture 
of the cardiac isoform and the ~mino acid sequence of 
the phosphorylation site is conserved between all spe- 
cies so far examined including that of man [8,16]. 
In rat and chick, a developmental isoform oftroponin 
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I has been described in fetal heart which is indistinguish- 
able from that present in slow skeletal muscle [5,6,17]. 
In rat, this is the only isoform found during early car- 
diac development, and there is a transition to expression 
of Tnlc during the perinatal period [5,6]. Moreover, 
molecular cloning has shown that this is associated with 
a transition in the accumulation of mRNAs encoding 
Tnls and Tnlc [ 13]. In chick the situation is different as 
both This and Tnlc are expressed at all stages of cardiac 
development examined in ovo, with Tnls being lost 
post-hatching [6]. In man, few studies have been carried 
out on troponin expression during cardiac develop- 
ment, and no developmental isoforms of troponin I
have been described in the fetal heart (e.g. [18]). 
Here we describe the presence of a developmental 
isoform of troponin I in the human fetal heart, and 
demonstrate that this isoform corresponds to that 
found in slow skeletal muscle. 
2. MATERIALS AND METHODS 
2.1, A,Tt/!..:d?. s used for troponin I detection 
Mo.no;'~,~aal ntibodies used for the detection of human troponin 
1 isofoi~s were derived from previously described clones [19]. Anti- 
body derived from clone 42/25 specifically reacts with all three tropo- 
nin I isoforms in chicken and rat [6]. Sheep polyclonal antibody was 
prepared using troponin I isolated from human heart and has been 
previously shown to be specific for this isoform in both man and rat 
[7]. 
2.2. Preparation of protein extracts and immunoblotting 
Cardiac muscle was obtained from elective abortions, from autopsy 
and from samples taken at the time of surgery and stored in liquid 
nitrogen prior to use. Age of fetal samples was determined by foot 
measurement and quoted figures refer to gestational ge. All samples 
were judged to be from non-pathological tissue. Proteins were pre- 
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pared by pulverising tissue while frozen, followed by homogenising in 
1% SDS. Protein concentrations were determined [20] and 50 /zg 
samples were run on 10% polyacrylamide g ls containing I% SDS [21]. 
Following electrophoresis, gels were equilibrated in 20 mM Tris base/ 
150 mM glycine and electroblottcd onto nitrocellulose filters. Western 
blots were stained with antibody diluted 1/3000 (42/25) or 1/10 000 
(cardiac-specific) in phosphate-buffered saline containing 0 .1% 
Tween 20. Peroxidase-linked rabbit antibodies to mouse or sheep 
immunoglobulins (Dakopatts) were used to localize primary antibody 
binding [6]. 
I 
2.3. RN,q preparation and Northern blot analysis 
RNA was prepared from cardiac and skeletal muscle samples using 
guanidium isothiocyanate and CsCI ecntrifugation [22]. Northern 
blots were prepared using 20~g of total RNA run on 1.5% agarose- 
formaldehyde gels [23] and transferred to Hybond N+ membranes 
(Amersham UK) according to manufacturers specifications. A eDNA 
fragment containing 3'non-coding sequence of human This mRNA 
was generated by polymerase chain reaction as follows: 50 pmol of 
each of two primers (5"-GCTCTGAGCCTCCTGCTT-3' and 5'- 
GTTTAATCCAG'I-fCCA-3') were added to 500 ng human genomic 
DNA, 100 mM each of dATP, dCTP, d'I-FP and dGTP in 10 mM 
Tris-HCl (pH 8.4), 50 mM KCI, 600/IM MgCI:, 100/.tg/ml bovine 
serum albumin, and annealed by heating to 94°C for 5 min and cooling 
to 55°C. Taq polymerase (NBL) was added and 30 cycles carried out 
at 72°C (2 rain), 94°C (I rain) and 55°C (2 min). The resulting 136 
bp DNA fragment was isolated by separating the PCR products on 
Nusieve agarose (FMC Bioproducts) and cutting out the appropriate 
band. 3ZP-labelled probes were prepared from the Tnls eDNA frag- 
ment or from the insert of clone pCTI-2 encoding Tnlc [8] by priming 
using standard conditions [23]. 
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3. RESULTS 
3.1. Detection of troponin isofortns present hi the human 
heart 
Fig. 1A shows total protein extracts from adult and 
fetal heart analysed on Western blots using previously 
characterised monoclonal antibodies. Antibody 42/25 
has previously been shown to detect all three isoforms 
of troponin I (Tnlf, This and Tnlc) in chicken and rat 
[6], or data demonstrate hat this is also true for man. 
In adult cardiac (atrial) muscle a single protein band is 
detected corresponding to Tnlc, whereas in fetal skele- 
tal muscle, which contains a mixed population of fast 
and slow muscle fibres, two protein bands are detected 
corresponding to Tnlf and This. The relative position 
of human Tnls and Tnlfwas determined by comparison 
with published ata for human troponin isoforms (e.g. 
[3]). 
In fetal heart at 8 weeks, a single predominant band 
is seen which is clearly different from Tnlc, but which 
is indistinguishable from that of Tnls on the basis of its 
electrophoretic m,')bility. In the 33-week fetal heart sam- 
ple the same band is seen together with Tnlc. This band 
is not seen in the adult atrial sample. Fig. 1 B shows a 
parallel filter hybridized with antibody specific for car- 
diac troponin I [7], and no bands are seen in the human 
fetal skeletal muscle track demonstrating the specificity 
of detection using this antibody. In the 8-week fetal 
heart sample trace amounts of Tnlc are visible using 
this antibody, but the predominant troponin protein 
i , 
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Fig. 1. Detection of troponin I isoforms in human heart. Parallel 
immunoblots of protein extracts from 8-week fetal heart (lane I), 
33-week fetal heart (lane 2), adult atrial muscle (lane 3) and fetal 
skeletal muscle (lane 4). (A) Detection of troponin isoforms with 
antibody 42/25 which detects all three isoforms Tnlc (C), Tnls (S) and 
Tnlf (F). (B) Detection of parallel samples with sheep olyclonal 
antibody specific for cardiac troponin I.
detected with antibody 42/25 in Fig. 1A, is not detected. 
In the 33-week fetal heart and adult atrial samples the 
major band seen in Tnlc. A second, minor band which 
runs at a similar position to Tnlfis also detected in these 
samples. This is almost certainly a breakdown product 
of Tnlc. Firstly, because it is detected with the cardiac- 
specific antibody whereas Tnlf is not and secondly, be- 
cause it is more evident in samples where protein degra- 
dation is apparent (data not shown) as has been previ- 
ously described [3]. Together, these data suggest that the 
slow skeletal muscle troponin I isoform is expressed in 
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taken from 33-week fetal and 15-day neonatal heart 
contain Tnls with increasing amounts of Tnlc. How- 
ever, the 9-month postnatal heart sample contained 
only TnIc. This demonstrates a transition in troponin 
expression which occurs between 20 weeks fetal devel- 
opment and 9 months postnatal life and which involves 
increased accumulation of Tnlc and the loss of Tnls 
over this period. 
4. DISCUSSION 
1 2 3 4 5 6 
Fig. 2. Detection of slow TnI mRNA in fetal heart. RNA from fetal 
hearts of ages 8 weeks (lane I), 12 weeks (lane 2), 14 weeks (lane 3) 
and 28 weeks (lane 4) together with fetal skeletal muscle (lane 5) and 
adult atrial muscle (lane 6) was analysed by Northern blotting. Fol- 
lowing hybridization with a PCR-derived probe specific for Tnls 
mRNA (see text), a single band is seen in both fetal heart and fetal 
skeletal muscle samples confirming the presence of This rnRNA in the 
fetal (but not adult) heart. 
human fetal heart, and that it constitutes the predomi- 
nant troponin I isoform in early cardiac development. 
3.2. Detection of mRNA for slow tropon& I &fetal heart 
If Tnls is expressed in the fetal heart then mRNA 
encoding this isoform should be present. In order to 
detect slow Tnls mRNA, we made a PCR-derived 
cDNA fragment corresponding to the 3" non-coding 
region of the Tnls mRNA using published sequence 
data [11]. This region of the Tnls sequence has previous- 
ly been demonstrated to be isoform-specific [11] but in 
order to verify the specificity of our PCR-derived 
cDNA fragment, we carried out Southern blot hybridi- 
zation to digests of human genomic DNA. This resulted 
in the same pattern of single-copy bands (data not  
shown) as previously described for the Tnls gone [11]. 
Fig. 2 shows a Northern blot of total RNA extracts 
from several fetal heart samples (8-, 12-, 14- and 28- 
week), fetal skeletal muscle and adult atrial muscle, fol- 
lowing hybridization with the Tnls cDNA probe. A 
single mRNA band is seen in all the fetal heart tracks 
as well as with fetal skeletal muscle, thereby confirming 
the presence of This mRNA in fetal heart. No hybridi- 
zation is seen with adult atrial RNA. The level of signal 
shows an apparent decrease with developmental ge in 
the fetal heart samples. 
We have demonstrated that there is a transition in 
expression of troponin I isoforms during fetal develop- 
ment of the human heart from slow TnI (Tnls) which 
is the major isoform in early fetal heart, to cardiac 
troponin I (Tnlc), the adult isoform. This transition 
occurs over a period from 20 weeks gestation and 9 
months postnatal development. Expression of slow 
skeletal muscle troponin I in fetal heart has been 
previously described for rat and chick and would 
appear to be a common feature of cardiac development 
in vertebrates. 
The troponin complex is involved in the regulation of 
striated muscle contraction and trop0nin I probably 
acts as a molecular switch which regulates the interac- 
tion of actin and myosin in response to calcium (e.g. 
[24]). As Tnls and Tnlc are structurally different, transi- 
tion in expression from Tnls to Tnlc during fetal devel- 
opment is of importance when considering contractility 
in the developing heart. Tnlc has an extended N-ter- 
minal sequence which contains two serine residues 
which are phosphorylated in response to adrenergic 
stimulation. Phosphorylation at these sites is probably 
effected by cAMP-dependent protein kinase and results 
in altered contractile properties of the myocardium 
(reviewed in [25]) including increased rate of relaxation 
[26]. Our data suggest hat early fetal heart contains 
predominantly Tnls. As this isoform lacks the N-ter- 
minal serine residues involved in this phosphorylation 
it would be expected to confer reduced responsiveness 
to adrenergic stimulation and the developmental transi- 
tion to expression of the adult Tnlc isoform should 
result in a developmental increase in responsiveness. 
The molecular mechanisms which effect changes in tro- 
c-~ ~'~..;i,~ : .  ~ ~ ~ ~-c 
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3.3. Timhrg of transitions in troponin I expression 
To further investigate the transition in accumulation 
from Tnls to Tnlc we examined a series of fetal and 
postnatal heart samples. Fig. 3 shows samples analysed 
on Western blots with troponin isoforms detected with 
antibody 42/25. As expected from our initial observa- 
tions, all early fetal samples contain a single predo- 
minant protein band correspo:~ding to Tnls. Samt~tes 
1 2 3 4 5 6 7 8 
Fig. 3. Transition in troponin I expression during fetal cardiac devel- 
opment. Immunoblot of protein extracts from fetal heart at 8 weeks 
(lane 1), I1 weeks (lane 2), 14 weeks (lane 3), 20 weeks (lane 4) and 
33 weeks (lane 5) gestation, 15-day (lane 6) and 9-month (lane 7) 
postnatal heart and fetal skeletal muscle (lane 8), following detection 
with antibody 42/25, C, S and F indicate the positions of Tnlc, This 
and Tnlf, respectively. 
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ponin I expression in the heart are unknown although 
developmental changes in hormone levels, in particular 
thyroid hormone, may play a direct role [27]. Further 
experiments aimed at elucidating the exact timing and 
level of control are needed to address this issue. 
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